Motegi K, Tanonaka K, Takenaga Y, Takagi N, Takeo S
Department of Molecular and Cellular Pharmacology, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan.
Br J Pharmacol. 2007 Aug;151(7):963-78. doi: 10.1038/sj.bjp.0707321. Epub 2007 Jun 4.
Na+/Ca2+ exchanger (NCX) inhibitors are known to attenuate myocardial reperfusion injury. However, the exact mechanisms for the cardioprotection remain unclear. The present study was undertaken to examine the mechanism underlying the cardioprotection by NCX inhibitors against ischaemia/reperfusion injury.
Isolated rat hearts were subjected to 35-min ischaemia/60-min reperfusion or 20-min ischaemia/60-min reperfusion. NCX inhibitors (3-30 microM KB-R7943 (KBR) or 0.3-1 microM SEA0400 (SEA)) were given for 5 min prior to ischaemia (pre-ischaemic treatment) or for 10 min after the onset of reperfusion (post-ischaemic treatment).
With 35-min ischaemia/60-min reperfusion, pre- or post-ischaemic treatment with KBR or SEA neither enhanced post-ischaemic contractile recovery nor attenuated ischaemia- or reperfusion-induced Na+ accumulation and damage to mitochondrial respiratory function. With the milder model (20-min ischaemia/reperfusion), pre- or post-ischaemic treatment with 10 microM KBR or 1 microM SEA significantly enhanced the post-ischaemic contractile recovery, associated with reductions in reperfusion-induced Ca2+ accumulation, damage to mitochondrial function, and decrease in myocardial high-energy phosphates. Furthermore, Na+ influx to mitochondria in vitro was enhanced by increased concentrations of NaCl. KBR (10 microM) and 1 microM SEA partially decreased the Na+ influx.
The NCX inhibitors exerted cardioprotective effects during relatively mild ischaemia. The mechanism may be attributable to prevention of mitochondrial damage, possibly mediated by attenuation of Na+ overload in cardiac mitochondria during ischaemia and/or Ca2+ overload via the reverse mode of NCX during reperfusion.
已知钠钙交换体(NCX)抑制剂可减轻心肌再灌注损伤。然而,心脏保护的确切机制仍不清楚。本研究旨在探讨NCX抑制剂对缺血/再灌注损伤的心脏保护作用机制。
将离体大鼠心脏进行35分钟缺血/60分钟再灌注或20分钟缺血/60分钟再灌注。在缺血前5分钟(缺血前处理)或再灌注开始后10分钟(缺血后处理)给予NCX抑制剂(3 - 30微摩尔KB-R7943(KBR)或0.3 - 1微摩尔SEA0400(SEA))。
在35分钟缺血/60分钟再灌注时,用KBR或SEA进行缺血前或缺血后处理,既未增强缺血后收缩功能恢复,也未减轻缺血或再灌注诱导的钠蓄积以及对线粒体呼吸功能的损害。在较轻度模型(20分钟缺血/再灌注)中,用10微摩尔KBR或1微摩尔SEA进行缺血前或缺血后处理可显著增强缺血后收缩功能恢复,同时伴有再灌注诱导的钙蓄积减少、线粒体功能损害减轻以及心肌高能磷酸盐减少。此外,体外增加氯化钠浓度可增强钠流入线粒体。10微摩尔KBR和1微摩尔SEA可部分减少钠流入。
NCX抑制剂在相对轻度缺血期间发挥心脏保护作用。其机制可能归因于预防线粒体损伤,这可能是通过减轻缺血期间心脏线粒体钠超载和/或再灌注期间通过NCX反向模式的钙超载介导的。